Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction
- PMID: 2872054
- DOI: 10.1007/BF00615955
Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction
Abstract
Theoretically the increased sympathoadrenal activity following acute myocardial infarction might augment the haemodynamic impact of beta-adrenoceptor blockade. To evaluate this question 32 haemodynamic studies were performed to compare the effects of equivalent beta-blocking doses of propranolol (8 mg i.v.) and pindolol (0.8 mg i.v.) in patients with a recent acute myocardial infarction (A.M.I.) or stable coronary artery disease (and a presumptive low sympathetic state). In stable coronary artery disease there were clear differences between the haemodynamic impact of propranolol and pindolol. Propranolol decreased both heart rate (delta HR -7 beat/min) and cardiac index (delta CI -0.4 l/min/m2), with an increased pulmonary artery occluded pressure (delta PAOP +4 mmHg) and systemic vascular resistance index (delta SVRI +358 dyn X s X cm-5 m2). However an equivalent beta-blocking dose of pindolol increased PAOP (delta PAOP +3 mmHg) leaving other variables unchanged. These differential actions of propranolol and pindolol have previously been ascribed to the intrinsic sympathomimetic activity (I.S.A.) of pindolol maintaining cardiac pumping function in a low sympathetic state. In contrast following myocardial infarction, both drugs reduced cardiac index to a significantly greater extent compared with stable coronary artery disease (delta CI propranolol -0.81/min/m2; pindolol -0.4 l/min/m2; p less than 0.05); propranolol also reduced the systemic arterial blood pressure (delta systolic -10 mmHg; delta mean -5 mmHg; p less than 0.05). The haemodynamic relevance of the I.S.A. of pindolol appeared attenuated following A.M.I. These data are compatible with experimental evidence of sympathetic nervous activation following coronary occlusion; the resulting hyperadrenergic state appears to condition an augmented haemodynamic response to beta-blocking drugs irrespective of their ancillary pharmacological properties.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Is the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds relevant in acute myocardial infarction?Eur J Clin Pharmacol. 1984;27(5):509-15. doi: 10.1007/BF00556884. Eur J Clin Pharmacol. 1984. PMID: 6151504 Clinical Trial.
-
Beta-blockade in ischaemic heart disease--influence of concomitant ISA or alpha-blockade on haemodynamic profile.Postgrad Med J. 1983;59 Suppl 3:45-52. Postgrad Med J. 1983. PMID: 6359109 Clinical Trial.
-
Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease.Eur J Clin Pharmacol. 1983;25(2):157-65. doi: 10.1007/BF00543785. Eur J Clin Pharmacol. 1983. PMID: 6628498 Clinical Trial.
-
Clinical pharmacology of pindolol.Am Heart J. 1982 Aug;104(2 Pt 2):346-56. doi: 10.1016/0002-8703(82)90125-9. Am Heart J. 1982. PMID: 6125094 Review.
-
Beta-adrenergic blockade for survivors of acute myocardial infarction.N Engl J Med. 1984 Mar 29;310(13):830-7. doi: 10.1056/NEJM198403293101306. N Engl J Med. 1984. PMID: 6142420 Review. No abstract available.
Cited by
-
Exploring Sex Differences of Beta-Blockers in the Treatment of Hypertension: A Systematic Review and Meta-Analysis.Biomedicines. 2023 May 22;11(5):1494. doi: 10.3390/biomedicines11051494. Biomedicines. 2023. PMID: 37239165 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical